Newbury Pharmaceuticals AB (OSTO:NEWBRY) EV-to-Revenue : 2.89 (As of Jun. 04, 2024)

View and export this data going back to 2022. Start your Free Trial

What is Newbury Pharmaceuticals AB EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Newbury Pharmaceuticals AB's enterprise value is kr65.88 Mil. Newbury Pharmaceuticals AB's Revenue for the trailing twelve months (TTM) ended in Feb. 2024 was kr22.83 Mil. Therefore, Newbury Pharmaceuticals AB's EV-to-Revenue for today is 2.89.

The historical rank and industry rank for Newbury Pharmaceuticals AB's EV-to-Revenue or its related term are showing as below:

OSTO:NEWBRY' s EV-to-Revenue Range Over the Past 10 Years
Min: 2.05 Med: 10.15 Max: 67.1
Current: 2.89

During the past 3 years, the highest EV-to-Revenue of Newbury Pharmaceuticals AB was 67.10. The lowest was 2.05. And the median was 10.15.

OSTO:NEWBRY's EV-to-Revenue is ranked worse than
59.73% of 1023 companies
in the Drug Manufacturers industry
Industry Median: 2.28 vs OSTO:NEWBRY: 2.89

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-06-04), Newbury Pharmaceuticals AB's stock price is kr2.98. Newbury Pharmaceuticals AB's Revenue per Share for the trailing twelve months (TTM) ended in Feb. 2024 was kr1.17. Therefore, Newbury Pharmaceuticals AB's PS Ratio for today is 2.55.

Newbury Pharmaceuticals AB EV-to-Revenue Historical Data

The historical data trend for Newbury Pharmaceuticals AB's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Newbury Pharmaceuticals AB EV-to-Revenue Chart

Newbury Pharmaceuticals AB Annual Data

Trend

Aug21

Aug22

Aug23

EV-to-Revenue

9.67

6.78

Newbury Pharmaceuticals AB Quarterly Data
	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24
EV-to-Revenue	Get a 7-Day Free Trial									13.56	5.47	6.78	2.61	3.43

Competitive Comparison of Newbury Pharmaceuticals AB's EV-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Newbury Pharmaceuticals AB's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Newbury Pharmaceuticals AB's EV-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Newbury Pharmaceuticals AB's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Newbury Pharmaceuticals AB's EV-to-Revenue falls into.

Newbury Pharmaceuticals AB EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Newbury Pharmaceuticals AB's EV-to-Revenue for today is calculated as:

EV-to-Revenue	=	Enterprise Value (Today)	/	Revenue (TTM)
	=	65.879	/	22.827
	=	2.89

Newbury Pharmaceuticals AB's current Enterprise Value is kr65.88 Mil.
Newbury Pharmaceuticals AB's Revenue for the trailing twelve months (TTM) ended in Feb. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr22.83 Mil.

Newbury Pharmaceuticals AB (OSTO:NEWBRY) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Newbury Pharmaceuticals AB's PS Ratiofor today is calculated as:

PS Ratio	=	Share Price (Today)	/	Revenue per Share (TTM)
	=	2.98	/	1.17
	=	2.55

Newbury Pharmaceuticals AB's share price for today is kr2.98.
Newbury Pharmaceuticals AB's Revenue per Share for the trailing twelve months (TTM) ended in Feb. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr1.17.

Newbury Pharmaceuticals AB EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Newbury Pharmaceuticals AB's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Newbury Pharmaceuticals AB (OSTO:NEWBRY) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Newbury Pharmaceuticals AB (OSTO:NEWBRY) » Definitions » EV-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

Scheeletorget 1, Medicon Village, Lund, SWE, 223 81

Website

https://www.newburypharma.com

Newbury Pharmaceuticals AB is a hybrid pharmaceutical company for specialty prescription drugs, innovation and brands with focus on the Scandinavian markets.

Newbury Pharmaceuticals AB (OSTO:NEWBRY) Headlines

No Headlines